The rapid growth (and partial retreat) of “they” and “them” has gotten a lot of attention in recent years, but English is ...

Ethan Smith, therapy area director Oncology, Norstella, explores how antibody–drug conjugates are reshaping oncology, highlighting emerging challenges around treatment sequencing, safety management ...

As of Tuesday, January 13, Ligand Pharmaceuticals Incorporated’s LGND share price has dipped by 7.83%, which has investors questioning if this is right time to buy.

How will each sign navigate this year’s design trends? Astrologers and designers decode what your star sign says about how ...

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: ...

Given the multifaceted nature of ADCs, developers should have an integrated analytical toolkit. Three complementary approaches dominate the current landscape: Ligand Binding Assays (LBA): Ideal for ...

By Brad Sorensen, CFA NASDAQ:YDES YD Bio (NASDAQ:YDES) is an integrated biotechnology company that combines diagnostics, precision medicine, and regenerative ophthalmology under a single commercial ...

Looking for Ninjitsu Master of Elements codes? This Roblox game is inspired by the beloved LEGO spin-off franchise, with plenty of combat and opportunities to upgrade your fighter. Fortunately, you ...

Synaffix’s glycan-based antibody–drug conjugate technology is experiencing strong demand, based on its potential to improve safety and efficacy of cancer therapies without genetic engineering.

V-212 was well tolerated. Adverse events were predominantly mild to moderate in intensity, with a trend for increasing incidence of systemic reactogenicity with increasing dose level. The incidence of ...

Element 112 did not invite a lot of interest when theoretical nuclear physicists predicted the famous island of stable superheavy elements — elements that have a number of nucleons that leads to ...